Literature DB >> 16888093

Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes.

Karen M Pastos1, William B Slayton, Lisa M Rimsza, Linda Young, Martha C Sola-Visner.   

Abstract

Umbilical cord blood (CB) is a valuable source of stem cells for transplantation, but CB transplantations are frequently complicated by delayed platelet engraftment. The reasons underlying this are unclear. We hypothesized that CB- and peripheral-blood (PB)-derived megakaryocytes (MKs) respond differently to the adult hematopoietic microenvironment and to thrombopoietin (Tpo). To test this, we cultured CB- and PB-CD34(+) cells in adult bone marrow stromal conditioned media (CM) or unconditioned media (UCM) with increasing concentrations of recombinant Tpo and compared the effects of these conditions on CB-versus PB-MKs. PB-MKs reached highest ploidy in response to UCM + 100 ng/mL rTpo, and the addition of CM inhibited their maturation. In contrast, CB-MKs reached highest ploidy in CM without rTpo, and high rTpo concentrations (> 0.1 ng/mL) inhibited their maturation. This is the first evidence that human neonatal and adult MKs have substantially different biologic responses to Tpo and potentially to other cytokines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16888093      PMCID: PMC1895431          DOI: 10.1182/blood-2006-04-018036

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

Authors:  Stephen Couban; David R Simpson; Michael J Barnett; Christopher Bredeson; Lothar Hubesch; Kang Howson-Jan; Tsiporah B Shore; Irwin R Walker; Peter Browett; Hans A Messner; Tony Panzarella; Jeffrey H Lipton
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

2.  Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release.

Authors:  Gianfranco Mattia; Francesca Vulcano; Luisa Milazzo; Alessandra Barca; Giampiero Macioce; Adele Giampaolo; H Jane Hassan
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

3.  Developmental differences in megakaryocyte maturation are determined by the microenvironment.

Authors:  William B Slayton; David A Wainman; Xiao Miao Li; Zhongbo Hu; Anil Jotwani; Christopher R Cogle; Danielle Walker; Robert C Fisher; John R Wingard; Edward W Scott; Martha C Sola
Journal:  Stem Cells       Date:  2005-10       Impact factor: 6.277

4.  Dose-response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and non-thrombocytopenic neonates to recombinant thrombopoietin.

Authors:  M C Sola; Y Du; A D Hutson; R D Christensen
Journal:  Br J Haematol       Date:  2000-08       Impact factor: 6.998

5.  Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies.

Authors:  G F Sanz; S Saavedra; D Planelles; L Senent; J Cervera; E Barragán; C Jiménez; L Larrea; G Martín; J Martínez; I Jarque; F Moscardó; G Plumé; R Andreu; A I Regadera; I García; S Mollá; P Solves; J de La Rubia; P Bolufer; L Benlloch; M A Soler; M L Marty; M A Sanz
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

6.  Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

Authors:  John E Wagner; Juliet N Barker; Todd E DeFor; K Scott Baker; Bruce R Blazar; Cindy Eide; Anne Goldman; John Kersey; William Krivit; Margaret L MacMillan; Paul J Orchard; Charles Peters; Daniel J Weisdorf; Norma K C Ramsay; Stella M Davies
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

7.  Megakaryocytes and megakaryocyte progenitors in human cord blood.

Authors:  T A Olson; R F Levine; E M Mazur; D G Wright; A J Salvado
Journal:  Am J Pediatr Hematol Oncol       Date:  1992-08

8.  Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development.

Authors:  K Kaushansky; V C Broudy; N Lin; M J Jorgensen; J McCarty; N Fox; D Zucker-Franklin; C Lofton-Day
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

9.  Thrombopoietin promotes mixed lineage and megakaryocytic colony-forming cell growth but inhibits primitive and definitive erythropoiesis in cells isolated from early murine yolk sacs.

Authors:  Xiaodong Xie; Rebecca J Chan; Scott A Johnson; Mark Starr; Jennifer McCarthy; Reuben Kapur; Mervin C Yoder
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

10.  Developmental changes in human megakaryocyte ploidy.

Authors:  E Hegyi; M Nakazawa; N Debili; S Navarro; A Katz; J Breton-Gorius; W Vainchenker
Journal:  Exp Hematol       Date:  1991-02       Impact factor: 3.084

View more
  20 in total

1.  Two patterns of thrombopoietin signaling suggest no coupling between platelet production and thrombopoietin reactivity in thrombocytopenia-absent radii syndrome.

Authors:  Janine Fiedler; Gabriele Strauss; Martin Wannack; Silke Schwiebert; Kerstin Seidel; Katja Henning; Eva Klopocki; Markus Schmugge; Gerhard Gaedicke; Harald Schulze
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

2.  How I transfuse red blood cells and platelets to infants with the anemia and thrombocytopenia of prematurity.

Authors:  Ronald G Strauss
Journal:  Transfusion       Date:  2008-01-07       Impact factor: 3.157

3.  Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation.

Authors:  Massimo Dominici; Valeria Rasini; Rita Bussolari; Xiaohua Chen; Ted J Hofmann; Carlotta Spano; Daniela Bernabei; Elena Veronesi; Filippo Bertoni; Paolo Paolucci; PierFranco Conte; Edwin M Horwitz
Journal:  Blood       Date:  2009-05-11       Impact factor: 22.113

4.  Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles.

Authors:  Robert Flaumenhaft; James R Dilks; Jennifer Richardson; Eva Alden; Sunita R Patel-Hett; Elisabeth Battinelli; Giannoula L Klement; Martha Sola-Visner; Joseph E Italiano
Journal:  Blood       Date:  2008-09-18       Impact factor: 22.113

5.  Differences between newborn and adult mice in their response to immune thrombocytopenia.

Authors:  Zhongbo Hu; William B Slayton; Lisa M Rimsza; Matthew Bailey; Hannes Sallmon; Martha C Sola-Visner
Journal:  Neonatology       Date:  2010-02-04       Impact factor: 4.035

Review 6.  Neonatal thrombocytopenia and megakaryocytopoiesis.

Authors:  Francisca Ferrer-Marin; Zhi-Jian Liu; Ravi Gutti; Martha Sola-Visner
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

Review 7.  Regulation of the genetic code in megakaryocytes and platelets.

Authors:  M T Rondina; A S Weyrich
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

Review 8.  Linkage between the mechanisms of thrombocytopenia and thrombopoiesis.

Authors:  Koji Eto; Shinji Kunishima
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

Review 9.  Megakaryocyte ontogeny: Clinical and molecular significance.

Authors:  Kamaleldin E Elagib; Ashton T Brock; Adam N Goldfarb
Journal:  Exp Hematol       Date:  2018-03-02       Impact factor: 3.084

10.  Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.

Authors:  Viola Lorenz; Haley Ramsey; Zhi-Jian Liu; Joseph Italiano; Karin Hoffmeister; Sihem Bihorel; Donald Mager; Zhongbo Hu; William B Slayton; Benjamin T Kile; Martha Sola-Visner; Francisca Ferrer-Marin
Journal:  Thromb Haemost       Date:  2017-12-06       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.